About
Askel Healthcare Ltd is a Finnish medical technology company founded in 2017, specializing in knee cartilage repair solutions. The company emerged from over a decade of research in orthopedic surgery, cell biology, tissue engineering, and biomaterials at the Universities of Helsinki and Tampere. Its mission is to keep people in motion by providing an easy-to-implant cartilage repair solution that promotes fast recovery to pain-free activity. The flagship product, the COPLA® Cartilage Implant, is designed to repair knee cartilage defects. This innovative device is currently in the clinical phase and has received FDA Breakthrough Device Designation, indicating its potential to significantly improve patient outcomes. Askel Healthcare aims to obtain market authorizations in the European Union and the United States, with plans to launch the COPLA® implant by 2030. The company targets patients suffering from knee cartilage defects and osteoarthritis, conditions that can greatly affect quality of life. With a specialized team of fewer than 25 employees, Askel Healthcare is positioned to become a leader in orthopedic care.
Technologies
Keywords
Company Information
-
Employees 8
-
Founded 2017
-
Total Funding $852824
Location
3 Naulakatu, Tampere, Pirkanmaa, Finland, 33100
